Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1985 1
1986 1
1987 1
1988 4
1989 2
1990 2
1991 3
1992 6
1993 8
1994 19
1995 9
1996 15
1997 10
1998 10
1999 13
2000 19
2001 13
2002 5
2003 13
2004 5
2005 5
2006 6
2007 3
2008 4
2009 2
2010 4
2011 2
2012 2
2013 1
2014 5
2015 1
2016 3
2017 5
2018 5
2019 10
2020 4
2021 1
2022 6
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

225 results

Results by year

Filters applied: . Clear all
Page 1
Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas.
Donehower LA, Soussi T, Korkut A, Liu Y, Schultz A, Cardenas M, Li X, Babur O, Hsu TK, Lichtarge O, Weinstein JN, Akbani R, Wheeler DA. Donehower LA, et al. Among authors: soussi t. Cell Rep. 2019 Jul 30;28(5):1370-1384.e5. doi: 10.1016/j.celrep.2019.07.001. Cell Rep. 2019. PMID: 31365877 Free PMC article.
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation.
Malcikova J, Tausch E, Rossi D, Sutton LA, Soussi T, Zenz T, Kater AP, Niemann CU, Gonzalez D, Davi F, Gonzalez Diaz M, Moreno C, Gaidano G, Stamatopoulos K, Rosenquist R, Stilgenbauer S, Ghia P, Pospisilova S; European Research Initiative on Chronic Lymphocytic Leukemia (ERIC) — TP53 network. Malcikova J, et al. Among authors: soussi t. Leukemia. 2018 May;32(5):1070-1080. doi: 10.1038/s41375-017-0007-7. Epub 2018 Feb 2. Leukemia. 2018. PMID: 29467486 Free PMC article. Review.
Letter to the editor.
Soussi T. Soussi T. Hum Mol Genet. 2023 Jun 19;32(13):2121-2123. doi: 10.1093/hmg/ddad037. Hum Mol Genet. 2023. PMID: 36897275 No abstract available.
TP53: an oncogene in disguise.
Soussi T, Wiman KG. Soussi T, et al. Cell Death Differ. 2015 Aug;22(8):1239-49. doi: 10.1038/cdd.2015.53. Epub 2015 May 29. Cell Death Differ. 2015. PMID: 26024390 Free PMC article. Review.
TP53 and 53BP1 Reunited.
Soussi T, Kroemer G. Soussi T, et al. Trends Cell Biol. 2017 May;27(5):311-313. doi: 10.1016/j.tcb.2016.10.004. Epub 2016 Nov 17. Trends Cell Biol. 2017. PMID: 27866833 Free article.
p53 mutation heterogeneity in cancer.
Soussi T, Lozano G. Soussi T, et al. Biochem Biophys Res Commun. 2005 Jun 10;331(3):834-42. doi: 10.1016/j.bbrc.2005.03.190. Biochem Biophys Res Commun. 2005. PMID: 15865939 Review.
[Bcl2-associated X protein].
Soussi T. Soussi T. Bull Cancer. 2001 Mar;88(3):231-2. Bull Cancer. 2001. PMID: 11313197 Free article. French. No abstract available.
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-2024 update.
Malcikova J, Pavlova S, Baliakas P, Chatzikonstantinou T, Tausch E, Catherwood M, Rossi D, Soussi T, Tichy B, Kater AP, Niemann CU, Davi F, Gaidano G, Stilgenbauer S, Rosenquist R, Stamatopoulos K, Ghia P, Pospisilova S. Malcikova J, et al. Among authors: soussi t. Leukemia. 2024 May 16. doi: 10.1038/s41375-024-02267-x. Online ahead of print. Leukemia. 2024. PMID: 38755420 Review.
225 results